NCT04978168

Brief Summary

Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by the introduction of Peer Support Services.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 2, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

4.8 years

First QC Date

May 25, 2021

Last Update Submit

May 8, 2025

Conditions

Keywords

Opioid UseMedications for Opioid Use

Outcome Measures

Primary Outcomes (2)

  • Individual-Level Experimental (Period 2) Outcome: Engagement in MOUD

    Calculated from self-report survey of being enrolled in MOUD (yes or no) at each assessment.

    26 weeks

  • Program-Level Implementation Outcome: Engagement in MOUD

    MOUD engagement (primary implementation outcome) is defined as enrollment in MOUD treatment program, or filling a prescription for buprenorphine from a provider (in not on MOUD at time of recruitment), or remaining in MOUD treatment (if already on MOUD when recruited or at previous follow-up), coded dichotomously. Number of clients in probation enrolled in MOUD is tracked via medical and probation records.

    26 weeks

Secondary Outcomes (8)

  • Detainment during Assessment Period (Individual-Level Experimental (Period 2) Outcome)

    26 weeks

  • Opioid Use (Individual-Level Experimental (Period 2) Outcome)

    26 weeks

  • Non-Fatal Overdose Events (Individual-Level Experimental (Period 2) Outcome)

    26 weeks

  • Staff MOUD Knowledge and Attitudes (Program-Level Implementation Outcome)

    26 weeks

  • Organizational Readiness for Change (Program-Level Implementation Outcome)

    26 weeks

  • +3 more secondary outcomes

Study Arms (3)

Implementation Core

EXPERIMENTAL

During baseline Exploration, staff organizational surveys are collected. During Preparation, staff focus groups conduct needs assessment with system mapping of linkage points for screening, assessment, and referral, and the agencies/staff involved in these activities. During Implementation, sites use facilitated local change teams (LCT) provided with a core set implementation strategies to facilitate linkages between probation agencies and local community treatment providers. The LCTs identify barriers to change, approaches to overcome barriers, do goal selection using SMART (specific, measurable, achievable, relevant, timely) goals and evidence for medications, address stigma, and clarify needs/expectations/roles of probation officers and treatment providers, then choose and implement goals and strategies. Sustainability Phase: Facilitators work with LCTs for 12 months using a written action plan based on goal selection.

Behavioral: Core Intervention

Randomized Trial of Peer Support Specialist Model

EXPERIMENTAL

After Core implementation is complete, half of adult participants in probation who consent will be randomly assigned to a Peer Support Specialist (PSS) condition. PSS are assigned to adults diagnosed with OUD within 6 months of entry into probation, in addition to treatment as usual. PSS establish linkages to community providers (medical, mental health, substance use treatment); educate about recovery support services, transportation assistance, MOUD; provide experiential, non-clinical support to individuals with SUD; share skills, offer support for setting goals and navigating the recovery process); and provide referrals and support for treatment, housing, employment, drug court, and probation.

Behavioral: Peer Support Specialists (PSS)

Randomized to Treatment as Usual

ACTIVE COMPARATOR

After Core Implementation is complete, half of adult participants in probation who consent will be randomly assigned to continue with usual care.

Behavioral: Treatment as Usual (TAU)

Interventions

Staff are provided with a core set of implementation strategies to facilitate interorganizational linkages between probation agencies and local community treatment providers.

Implementation Core

Participants randomized to PSS will meet with a PSS for 6 months. Contact scheduled is flexible and based on the participant's needs and wants, plus written guidance for PSS-participant interactions.

Randomized Trial of Peer Support Specialist Model

Participants randomized to TAU will receive the services that will be offered at the time the Core Implementation intervention is completed.

Randomized to Treatment as Usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Community Provider Staff: Any front-line treatment provider at an agency participating in this study who: (a) provides support to MOUD clients, (b) has an active caseload including some individuals on probation, and (c) willing to commit to 12 months to the project.
  • Probation/Parole Staff: Any probation officer (PO) at an agency participating in this study who (a) has an active caseload, and (b) is willing to commit to 12 months to the project.
  • Individuals on Probation: (a) 18 years or older, (b) committed to probation within 90 days prior to study enrollment, (c) English speaking, (d) diagnosed with OUD, (e) have stable method of contact in community

You may not qualify if:

  • Individuals on Probation: Currently incarcerated or in a court-mandated inpatient treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Duke University

Durham, North Carolina, 27708, United States

RECRUITING

Temple University

Philadelphia, Pennsylvania, 19122, United States

RECRUITING

Brown University

Providence, Rhode Island, 02912, United States

RECRUITING

MeSH Terms

Conditions

Opioid-Related Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Rosemarie A Martin, PhD

    Brown University

    PRINCIPAL INVESTIGATOR
  • Damaris J Rohsenow, PhD

    Brown University

    PRINCIPAL INVESTIGATOR
  • Lauren Brinkley-Rubinstein, PhD

    Duke University

    PRINCIPAL INVESTIGATOR
  • Steven Belenko, PhD

    Temple University

    PRINCIPAL INVESTIGATOR
  • Lynda Stein, PhD

    University of Rhode Island

    PRINCIPAL INVESTIGATOR
  • Josiah Rich, MD

    The Miriam Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rosemarie A Martin, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: A Type 1 hybrid implementation-effectiveness study conducted in two phases. The first recruits as staff/leaders from probation agencies and community treatment agencies. The second phase (which starts after the implementation in the first period is completed) recruits adults on probation and staff of probation agencies. The Core Implementation study (first phase) involves a pre-post design. The effectiveness study (second phase) uses randomized parallel assignment with two arms. The initial Core Implementation study involved four phases: Exploration (baseline), Preparation, Implementation, Sustainability (6- and 12-month follow-ups). The subsequent Effectiveness study starts after the Implementation phase is completed, with its own baseline data and follow-ups up to 6 months.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2021

First Posted

July 27, 2021

Study Start

March 2, 2021

Primary Completion

December 30, 2025

Study Completion

April 30, 2026

Last Updated

May 13, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The coordinating center is charged with creating de-identified versions of agency staff and probation individual level data available at the end of the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data will become available after the results of the primary study analyses have been accepted for publication. The data will be available for five years.
Access Criteria
De-identified data will be shared with the Methodology and Advanced Analytics Resource Center (MAARC) of JCOIN and with qualified researchers on request to the MAARC.

Locations